MedTrace Logo

ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH)

NCT02880878 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-05-10

No results posted yet for this study

Summary

This is a multicenter, randomized, adaptive clinical trial comparing standard medical management to early (\<24 hours) surgical hematoma evacuation using minimally invasive parafascicular surgery (MIPS) in the treatment of acute spontaneous supratentorial intracerebral hemorrhage.

Conditions

  • Intracerebral Hemorrhage
  • Cerebral Hemorrhage
  • Intracerebral Haemorrhage

Interventions

PROCEDURE

Early Surgical Hematoma Evacuation

Early Minimally Invasive Parafascicular Surgery (MIPS)

Sponsors & Collaborators

  • Emory University

    collaborator OTHER

  • Nico Corporation

    lead INDUSTRY

Principal Investigators

  • Daniel Barrow, MD · 1-877-572-5511 | [email protected] | Emory University School of Medicine

  • Gustavo Pradilla, MD · 1-877-572-5511 | [email protected] | Emory University School of Medicine

  • Jonathan Ratcliff, MD, MPH · 1-877-572-5511 | [email protected] | Emory University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2022-08-31
Completion
2023-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02880878 on ClinicalTrials.gov